facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2017
vol. 104
 
Share:
Share:
abstract:
Meta-analysis

Treatment of atopic dermatitis with cyclosporin A: a case report

Karolina Kaaz
,
Adam Reich

Dermatol Rev/Przegl Dermatol 2017, 104, 432-438
Online publish date: 2017/09/15
View full text Get citation
 
PlumX metrics:
Introduction. Despite the progress that has been made in the therapy of atopic dermatitis in recent years, cyclosporin A remains the first-line treatment of severe forms of the disease.

Objective. To present a case of effective cyclosporin A therapy of severe atopic dermatitis with features of secondary bacterial infection.

Case report. A 22-year-old man was admitted to hospital with extensive erythematous-desquamative skin lesions. The lesions were accompanied by intense itching. Based on the patient’s medical history, physical examination, laboratory test results and histological examination of a skin biopsy, atopic dermatitis with bacterial superinfection was diagnosed. Treatment with cyclosporin A in combination with antibiotics was initiated, resulting in significant clinical improvement within a few days after the initiation of therapy.

Conclusions. Our case confirms that cyclosporin A is a fast-acting and highly effective therapeutic agent in atopic dermatitis, and the risk of adverse reactions, if the drug is used properly, is low.
keywords:

atopic dermatitis, treatment, secondary infection



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.